How to Buy Sight Sciences Stock
Sight Sciences Inc
Sight Sciences, Inc. , an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases.
Sight Sciences stock last closed at $2.76, up 3.76% from the previous day, and has decreased 48.6% in one year. It has underperformed other stocks in the Medical Devices industry by 0.3 percentage points. Sight Sciences stock is currently +35.96% from its 52-week low of $2.03, and -67.34% from its 52-week high of $8.45.
There are currently 51.33M SGHT shares outstanding. The market value of SGHT is $141.68M. In the past 24 hours, 118,434 SGHT shares were traded.
How to Buy Sight Sciences Stock
Wondering how to invest in Sight Sciences stock? Here's how.
- Choose where to buy Sight Sciences stock: You need to decide on a stock brokerage, but don't worry - we've tested dozens of online stock brokerages and apps to help you determine where to buy Sight Sciences stock.
- Sign up for a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
- Fund your brokerage account: Pick your payment method and add your information.
- Evaluate Sight Sciences stock: The Sight Sciences ticker symbol is SGHT. Is Sight Sciences stock a good investment? Should you buy shares of SGHT? How do SGHT's underlying business fundamentals look? Do top analysts think Sight Sciences is a good buy? Why has SGHT's stock price moved recently? (Hint: Our stock analysis website can help you figure out if SGHT is a good stock to buy).
- Place your SGHT buy order: Decide if you will purchase SGHT shares at the current market price or use a limit order to buy SGHT stock at a particular price.
- Get notifications regarding your investment in SGHT: Create a watchlist to monitor your new investment in Sight Sciences shares.
Step 1: Choose where to buy Sight Sciences stock
You will need a brokerage account in order to access the NASDAQ market and buy SGHT shares.
Our preferred brokerage: eToro
We believe that eToro is the best online stock brokerage. Here's why:
- Invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
- Access to global markets: From Tech to Energy, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading exchanges.
- Social investing: eToro has a community with more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your stock purchase by creating an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Sign up for a brokerage account
Now that you've chosen the right brokerage, you'll need to fill out some personal information so you are able to buy SGHT stock today.
How to Create a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal info to create your new brokerage account.
- Submit your details by pressing the "Create Account" button. Get started with eToro today
Step 3: Fund your brokerage account
Now that you have opened your account on the stock trading app, you need to deposit funds:
Check out this video walkthrough for more details transferring funds into your investment account.
Step 4: Evaluate Sight Sciences stock
Once you have selected the best place to buy Sight Sciences stock, it's important to evaluate their stock before you invest, so you can wrap your head around the risk and upside.
Sight Sciences shares at a glance
Sight Sciences Due Diligence Score
WallStreetZen was created to help average investors do more in-depth fundamental analysis in less time.
You can see all of the due diligence checks on SGHT's stock page.
What is the fair value of SGHT stock?
Investors use a variety of different financial metrics, analyses, models, and charts to gauge SGHT's intrinsic value.
Using relative valuations ratios:
- SGHT could be undervalued based on its P/B ratio of 1.62x, relative to Medical Devices industry P/B ratio of 3.74x
You can do additional valuation research on SGHT's stock here.
A look at SGHT Cashflows and Balance Sheet
Positive Financial Indicators:
- SGHT has $120.36M in cash and short term investments. This is enough to cover its annual cash burn of $22.74M.
- There are more short-term assets than short-term liabilities on the SGHT balance sheet.
- SGHT has cash burn of 22736000. It has sufficient cash and short-term investments to cover this for at least one year.
- There are more short-term assets than long-term liabilities on the SGHT balance sheet.
- Total SGHT debt is lower than 5 years ago, relative to shareholder equity.
Negative Financial Indicators:
- SGHT profit margin has gone up by 0.04 percentage points in the past year, but the company is still unprofitable.
- SGHT has a relatively high debt to equity ratio of 0.63.
Is it a good time to buy SGHT stock, according to Wall Street analysts?
Out of 6 Equities analysts who give forecasts on SGHT, the consensus analyst rating on Sight Sciences is a Buy
It's important to note that analyst ratings are not stock recommendations, nor are they financial advice.
Most Recent SGHT Analyst Upgrades/Downgrades
Cecilia Furlong, a bottom 13% analyst from Morgan Stanley maintains SGHT with a hold rating and lowers their SGHT price target from $7.00 to $5.00, on Nov 11, 2024.
You can dive deeper into what analysts are saying on the Sight Sciences stock forecast page.
SGHT Trading Indicators
SGHT Performance Numbers
Last year, SGHT revenue was $79.87M. Over the past five year, SGHT's revenue has gone up by 27.89% per year. This was faster than the Medical Devices industry average of 9.8%.
Dig into SGHT's earnings and revenue performance here.
What are SGHT executives and large shareholders up to?
In the last 12 months, executives and large shareholders at SGHT have bought more shares than they have sold.
Alison Bauerlein, Chief Financial Officer of SGHT, was the latest SGHT insider to sell. They sold $44,787.67 worth of SGHT stock on Apr 2, 2025.
Get more info about who owns SGHT shares here.
Does SGHT provide a stable income stream?
No, Sight Sciences doesn't provide an income stream by paying out dividends.
SGHT Social Trading Data
One of the reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to learn what other investors have to say.
Step 5: Place your SGHT buy order
You have two primary order types:
- Market order: A market order is an order to buy or sell a stock at the best available price.
Market orders are mostly fine for most investors. - Limit order: A limit order lets you buy or sell a security at a specific price (or better).
If you want to be certain you're buying or selling at an exact dollar amount limit, use a limit order.
Click the Open Trade button and your broker will place your order.
If you want additional info about investing in stocks on eToro, click the how to video below:
Step 6: Get notifications regarding your investment in SGHT
Now that you own some SGHT stock, you'll want to stay up-to-date on your company.
Start a watchlist to see the latest developments about your SGHT stock.
SGHT Feed
How to Buy Stock in Sight Sciences
To reiterate, here are the 6 steps you need to take to buy Sight Sciences stock right now:
- Choose where to buy Sight Sciences stock
- Sign up for a brokerage account
- Fund your brokerage account
- Evaluate Sight Sciences stock
- Place your SGHT buy order
- Get notifications regarding your investment in SGHT
If you need a brokerage, eToro is our recommended venue.
Get Started with eToro TodayIf you want to watch your new investment in Sight Sciences, add SGHT to your watchlist below.
Trending "How To" Guides
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.